s6y

4 Protagenic Therapeutics, Inc.\new: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001437749-16-034198

Documents

  1. FORM 4 4
  2. STEIN POA EX-24

On sec.gov